�鶹��Ƶ

In a paper published by the , researchers investigated the number of bowel cancers diagnosed outside of traditional screening programmes and the reasons why this may be. Screening for bowel cancer consists of a faecal immunochemical test and involves taking a sample of faeces to be examined for traces of blood.

Dr Robert Kerrison, Lecturer in Cancer Care at the �鶹��Ƶ, said:

“Bowel cancer is one of the biggest cancer killers in England. When diagnosed early, the disease is highly treatable. It is vital, therefore, that it is caught early, if we are to reduce of the number of deaths from bowel cancer. Screening is one of the best and most effective ways of detecting cancer early, as it allows us to test for the disease, before symptoms develop and I would urge those eligible to utilize the screening kits which are automatically sent to our homes for samples to be provided.

“It is very concerning that the majority of patients are receiving diagnoses via other routes, often at a time when the cancer is at a more advanced stage, as our research shows. There are a number of different reasons why people don’t take part in screening. One of the biggest reasons is that people often feel embarrassed when it comes to poo (the “poo taboo” as Deborah James describes it). We need to normalize this and help people understand the importance of screening, as it undoubtedly saves lives.”

Analysing data from over 400 patients with bowel cancer at St. Mark’s Hospital in Harrow, all of whom were eligible to take part in screening at the time of their diagnosis, the researchers found that over 60 percent of those not diagnosed through screening had never taken part in official programmes, and a smaller proportion (nearly 10 percent) had not kept up to date with regular screening. Those who had not kept up to date were more likely to be diagnosed with metastatic disease, when cancer spreads to a different part of the body and is more difficult to treat.

It was also uncovered that a considerable proportion of those who regularly participated in screening had received a normal or weak positive result that did not require further investigation and then had a subsequent positive diagnosis for the disease.

The research was conducted in collaboration with St Mark’s Hospital Harrow and University College London.

Notes to editors

• Data used in this research was taken between January 2017 and December 2020
• St Mark’s Bowel Cancer Screening is responsible for screening the London boroughs of Brent, Harrow and North Ealing.
• Dr Robert Kerrison is available for interview upon request &�Բ�����;
• Contact the �鶹��Ƶ press office: mediarelations@surrey.ac.uk &�Բ�����;